A phase I study of accelerated high dose epirubicin (HDE) and cisplatin with G-CSF support in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Smit, EF [1 ]
Postmus, PE [1 ]
机构：
[1] Vrije Univ Amsterdam, Acad Hosp, Dept Pulm Dis, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP143
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy
    Huisman, C
    Biesma, B
    Postmus, PE
    Giaccone, G
    Schramel, FMNH
    Smit, EF
    BRITISH JOURNAL OF CANCER, 2001, 85 (10) : 1456 - 1461
  • [2] Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy
    C Huisman
    B Biesma
    P E Postmus
    G Giaccone
    F M N H Schramel
    E F Smit
    British Journal of Cancer, 2001, 85 : 1456 - 1461
  • [3] Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer
    Gridelli, C
    DAprile, M
    Palmeri, S
    Curcio, C
    Rossi, A
    Gebbia, V
    Veltri, E
    Pepe, R
    Pistillucci, G
    Bianco, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 589 - 591
  • [4] Paclitaxel, carboplatin, and G-CSF in advanced non-small-cell lung cancer:: A phase I/II study
    Hübel, K
    Engert, A
    Schmitz, S
    Re, D
    Wassermann, K
    Ko, Y
    Schwandt, C
    Vetter, H
    Diehl, V
    Tesch, H
    ONKOLOGIE, 1998, 21 (04): : 310 - 314
  • [5] Multicentre phase II trial of accelerated high dose epirubicin and cisplatin followed by surgery in patients with locally advanced non-small cell lung cancer
    Smit, E
    Biesma, B
    Paul, M
    van der Tol, A
    Schramel, F
    Bolhuis, R
    Postmus, P
    LUNG CANCER, 2005, 49 : S174 - S174
  • [6] A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A cancer and leukemia group B study
    Graziano, SL
    Valone, FH
    Herndon, JE
    Crawford, J
    Richards, F
    Rege, VB
    Clamon, G
    Green, MR
    LUNG CANCER, 1996, 14 (2-3) : 315 - 329
  • [7] A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer
    Hobdy, EM
    Kraut, E
    Masters, G
    Blum, K
    McKeon, A
    Byrd, B
    Davies, M
    Beaulieu, N
    Murren, JR
    CANCER BIOLOGY & THERAPY, 2004, 3 (01) : 89 - 93
  • [8] PHASE-I STUDY OF EPIRUBICIN PLUS VINORELBINE WITH OR WITHOUT G-CSF IN ADVANCED NONSMALL CELL LUNG-CANCER
    GRIDELLI, C
    DEPLACIDO, S
    PEPE, R
    INCORONATO, P
    AIROMA, G
    ROSSI, A
    PALAZZOLO, G
    BIANCO, AR
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1729 - 1731
  • [9] Phase I/II study of paclitaxel, ifosfamide, and carboplatin with granulocyte colony-stimulating factor (G-CSF) support in advanced non-small cell lung cancer (NSCLC)
    Mauer, AM
    Ansari, RH
    Hoffman, PC
    Tembe, SA
    Gabrys, GT
    Szeto, L
    Vokes, EE
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 23 - 23
  • [10] Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer
    Gridelli, C
    Rossi, A
    Incoronato, P
    Bruni, GS
    Scognamiglio, F
    Ruffolo, P
    Rinaldi, L
    Bianco, AR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (06) : 613 - 615
12345